Do DPP4, KIT, and SELL biomarkers provide diagnostic value for HFpEF?
DPP4, KIT, and SELL are novel biomarkers that demonstrate excellent diagnostic performance for HFpEF.
In this study, we identified DPP4, KIT, and SELL as HFpEF-specific biomarkers. These three biomarkers, individually and combined in a predictive model, demonstrated excellent diagnostic performance, providing clinicians with a novel tool for rapid HFpEF diagnosis. Furthermore, our findings offer new insights into the complex pathophysiological mechanisms underlying HFpEF.
Chen et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: